Vinorelbine Tartrate
Medicare prescription drug cost, prescriptions and prescribers, 2024
$18K
Medicare cost, 2024
$18K
Medicare cost, 2024
Medicare drug plans spent $17,650 on Vinorelbine Tartrate in 2024, for 128 prescriptions and refills filled by 22 patients. Spending rose 32% from 2023 to 2024.
Medicare cost, 2024
$18K
+32.4% from 2023
Prescriptions
128
$137.89 per claim
Patients
22
17 prescribers
Total spending, 2024
$18K
$802.26 per patient
Questions and answers
How much does Medicare spend on Vinorelbine Tartrate?
Medicare prescription drug plans paid $18K for Vinorelbine Tartrate in 2024, for 128 prescriptions and refills to 22 patients (up 32.4% from 2023). The average cost per claim was $137.89.
Which state spends the most on Vinorelbine Tartrate?
New York had the highest Medicare cost for Vinorelbine Tartrate in 2024: $4,711 for 32 claims, followed by New Jersey ($2,470).
Who prescribes Vinorelbine Tartrate the most?
Trina Poretta, hematology-oncology in Voorhees, NJ, had the highest Medicare cost for Vinorelbine Tartrate in 2024: 36 claims costing $2,470.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Vinorelbine Tartrate was $18K in 2024, after a high of $28K in 2020.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Vinorelbine Tartrate, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 36 | Under 11 | $2,470 |
| Songchuan Guo Brooklyn, NY | Hematology-Oncology | 16 | Under 11 | $947 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 27 | 104 | 28 | $23K |
| 2023 | 19 | 89 | 20 | $13K |
| 2024 | 17 | 128 | 22 | $18K |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Sagent Pharmace | 99 | $13K |
| Actavis/Teva | 29 | $4,994 |
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 6,964 side-effect reports named vinorelbine tartrate (reports from 2003 on). 6,812 of them (97.8%) were serious, 1,477 named a death and 2,206 named a hospital stay. The reactions named most often were disease progression, malignant neoplasm progression and neutropenia. 1,929 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
6,964
354 in 2025 (-24.0% from 2024)
Serious
97.8%
6,812 reports
Deaths named
1,477
21.2% of reports
Hospital stays
2,206
31.7% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Vinorelbine Tartrate?
6,964 reports from 2003 through September 2026 named vinorelbine tartrate. 6,812 of them (97.8%) were serious, 1,477 named a death and 2,206 named a hospital stay.
What are the most reported side effects of Vinorelbine Tartrate?
790 reports named disease progression, the reaction named most often, followed by malignant neoplasm progression (710) and neutropenia (679). In the last 5 years the reaction named most often was disease progression (363 reports). A report can name several reactions.
How many side-effect reports named Vinorelbine Tartrate in 2025?
354 reports were received in 2025 (-24.0% from 2024). 2026 so far: 233 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Vinorelbine Tartrate caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Vinorelbine Tartrate caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
Side-effect reports from official public data, counted per active ingredient (vinorelbine tartrate) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.